In normal rats, angiotensin III is the predominant circulating angiotensin peptide, suggesting it may mediate aldosterone secretion in this species.
Answers are grounded in this paper and cite their sources.
Rat angiotensin III predominance should not inform human RAAS therapy; leaves open species-specific peptide distributions and aldosterone mediation.
Angiotensin II and its metabolites, [des-Asp-1]-angiotensin II (angiotensin III), [des-(Asp-1,Arg-2)]angiotensin II, and [des-(Asp-1,Arg-2,val-3)]angiotensin II, were measured in arterial and venous plasma from normal rats. Paper chromatography was used to separate the peptides which were measured with a radioimmunoassay method using an angiotensin II antiserum which had a 100% cross-reaction with each of these metabolites. A mean of 33% of the immunoreactive material in arterial plasma was angiotensin II, 58% angiotensin III, and 9% [des-(Asp-1,Arg-2)]angiotensin II/[des-(Asp-1,Arg-2,Val-3)]angiotensin II. A similar distribution was found in venous plasma. This and other evidence indicates that angiotensin-induced aldosterone secretion in the rat, unlike that in other mammalian species so far studied, may be mediated by angiotensin III.
No takes yet. Share an insight, caveat, or question.
Semple et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: